MGTX: Naylor Stuart discloses a sale

By AlphaYouPublished Oct 7, 2026Form 4

Stocks in this disclosure

Reported activity

Naylor Stuart

Reporting filer

Naylor Stuart reported Sale in MeiraGTx Holdings plc: 27659 units of Ordinary Shares, dated 2026-10-06. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 7, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Ordinary Shares	Naylor Stuart	2026-10-06	S	Sale	27659	10.64	613,187	1 day	Filed terms security Title: Ordinary Shares transaction Date: 2026-10-06 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 27659 transaction Price Per Share: 10.64 id: F2 id: F3 transaction Acquired Disposed Code: D shares Owned Following Transaction: 613187 direct Or Indirect Ownership: D nature Of Ownership:

Ordinary Shares

Owner: Naylor Stuart
Date: 2026-10-06
Code: S
Action: Sale
Quantity: 27659
Price: 10.64
Following holdings: 613,187
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Ordinary Shares
transaction Date: 2026-10-06
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 27659
transaction Price Per Share: 10.64
id: F2
id: F3
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 613187
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Naylor Stuart: CHIEF SCI OFCR, OPHTHALMOLOGY.
The filing reports a Rule 10b5-1 trading plan.
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025.
F2: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.53 to $10.88, inclusive.
F3: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Ordinary Shares

Naylor Stuart

2026-10-06

Sale

27659

10.64

613,187

1 day

Filed terms

security Title: Ordinary Shares
transaction Date: 2026-10-06
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 27659
transaction Price Per Share: 10.64
id: F2
id: F3
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 613187
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Naylor Stuart: CHIEF SCI OFCR, OPHTHALMOLOGY.

The filing reports a Rule 10b5-1 trading plan.

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2025.

F2: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.53 to $10.88, inclusive.

F3: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.